#USA #Clinical Trials #Conshohocken #Suvoda #Greenphire

Suvoda Innovates for a New Era in Clinical Trials

In the rapidly evolving world of clinical research, Suvoda is setting new standards through significant technological advancements aimed at improving the experience for both patients and trial sites. As a clinical trial technology company, Suvoda has made impressive progress in 2025, moving towards a more interconnected and efficient clinical trial experience.

One pivotal moment was Suvoda's merger with Greenphire, marking a substantial step toward addressing ongoing challenges in trial operations. This collaboration has enhanced Suvoda's capability to tackle the complexities of clinical studies with a unified approach, paving the way for a comprehensive ecosystem that reduces the intricacies throughout the lifecycle of clinical trials.

Key Developments

Jagath Wanninayake, the CEO of Suvoda, noted, "The past twelve months have been a significant step forward for Suvoda. Our meticulous approach to merging two robust companies, coupled with the launch of new functionalities tailored to the genuine needs of patients and trial sites, has been key. As we approach 2026, we focus on helping sponsors and trial sites manage their studies confidently while ensuring a seamless experience for patients."

Enhancing Patient Journeys

A major milestone was the introduction of Suvoda’s patient app, a clear example of how an integrated platform can significantly improve patient experiences in clinical trials. This app consolidates eCOA (electronic Clinical Outcome Assessment) questionnaires, patient payments, reminders, and study visit scheduling, all within a user-friendly interface accessible on personal devices. By engaging participants effectively, this innovation decreases administrative burdens on busy trial sites.

Utilizing AI to Streamline Operations

Suvoda’s efforts extend to employing AI through Sofia, an intelligent assistant developed for Suvoda IRT (Interactive Response Technology), with plans for broader application across the platform. Sofia enables study teams to access vital information efficiently, allowing users to pose questions and receive answers seamlessly, replacing complicated navigation with quick feedback. With strong data privacy measures and role-based controls, Sofia supports daily decision-making for research teams without compromising data integrity or study blinding.

Recognizing Innovation

Suvoda’s innovative approach received accolades in 2025, notably with a new patent for its platform architecture, bringing its total patents to five. The Everest Group recognized Suvoda as a leader in their RTSM PEAK Matrix® evaluation, a testament to the company's commitment to enhancing transparency, data quality, and user experience across its offerings. This ongoing focus on practical innovations reflects Suvoda's dedication to supporting real-world study operations effectively.

Looking Ahead to 2026

As Suvoda aims to build on its strong growth into 2026, the company anticipates a further increase in demand from pharmaceutical sponsors and Contract Research Organizations (CROs) seeking unified platforms to simplify study complexities while enriching patient and trial site experiences. Wanninayake stated, "In 2025, we not only merged two companies but also integrated our technologies, people, and mission. This foundation enables us to provide even greater value in 2026 and beyond. We are prepared to assist sponsors and trial sites in meeting their evolving needs, empowering patients to navigate their studies with ease and confidence."

About Suvoda

Suvoda is a global technology company specializing in clinical trials, offering a market-leading real-time software platform that empowers sponsors and CROs to make secure decisions while assisting sites and patients in executing studies efficiently and effectively. Suvoda provides connected, actionable software solutions and industry-best services and support to drive life-changing studies even in the most time-sensitive and mission-critical moments. Headquartered in the Philadelphia metropolitan area, Suvoda also has offices located in Portland, Barcelona, Bucharest, Iasi, and Tokyo. The company consistently exceeds industry average customer satisfaction scores, making it the top choice for sponsors and CROs involved in over 2000 studies across more than 95 countries. Recently, Suvoda merged with Greenphire, a leading provider of financial management and patient support tools for clinical trials. For more information, visit suvoda.com and follow Suvoda on LinkedIn.